Integrating routine hemoglobin A1c screening in blood donation: A strategy for early diabetes detection and donor health awareness
Transfusion · 2026-11 · 66 (11) · 2262-2272
DOI: 10.1111/trf.70238 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Transfusion, online erschienen am 08.06.2026. Verfasst von Yaseen Jamal und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Stanford University School of Medicine, Stanford, California, USA. Hauptthemen laut MEDLINE: Glycated Hemoglobin, Blood Donation, Blood Donors, Diabetes Mellitus. Die Arbeit nennt 21 Literaturangaben. Gefördert von: Abbott Laboratories.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Background
More than 1 in 10 adults worldwide have diabetes, with nearly 50% undiagnosed. Hemoglobin A1c (HbA1c) testing is widely available to identify disease status and blood donation centers can play a pivotal role in public health promotion with routine screening.
Methods
We performed a prospective observational study implementing HbA1c testing at a community blood center over a 1‐year period. Demographic data and history of pre‐diabetes/diabetes status were collected. Donors with abnormally elevated HbA1c without disease history were notified of a new diabetes/pre‐diabetes diagnosis.
Results
Overall, 17.7% of donors had elevated HbA1c levels. Strikingly, 64.9% of abnormal results represented new diagnoses, primarily pre‐diabetes (91.6%). Significant differences in the proportions of new diagnoses were found by donor type (whole blood, platelets) and demographic (age, gender, ethnicity). Donors with abnormal HbA1c values donated significantly more frequently than those with normal HbA1c values. Finally, 17.8% of donors with new diagnoses reported acknowledgement of the new diagnoses on a subsequent donation in the study period.
Conclusions
Incorporating HbA1c testing in blood donation centers is an effective strategy for early diabetes detection, underscored by the substantial proportion of new diagnoses. Further, observed differences across donation types and demographic groups reveal disproportionately underdiagnosed populations for targeted outreach. Moreover, enhanced follow‐up strategies are warranted to improve donor awareness of disease status. Finally, donation behavior changes were observed in those with pre/diabetes, highlighting the feasibility of incorporating screening, though distinct trends in subgroups define key considerations to optimize public health impact.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, Stanford University School of Medicine, Stanford, California, USA.
- Stanford Blood Center, Palo Alto, California, USA.
- Abbott Laboratories, Abbott Park, Illinois, USA.
ORCID-Profile: Yaseen Jamal, Suchitra Pandey
Förderung
- Abbott Laboratories
Zitieren
APA
Jamal, Y., Layon, A., Michelin, L., Mateo, D., Panesa, D., Meceda, P., Bevington, S., Hodghead, K., Bennett, J., Powers, L., Pandey, S., Kieffer, T., & Pham, T. (2026). Integrating routine hemoglobin A1c screening in blood donation: A strategy for early diabetes detection and donor health awareness. Transfusion, 66(11), 2262-2272. https://doi.org/10.1111/trf.70238
Vancouver
Jamal Y, Layon A, Michelin L, Mateo D, Panesa D, Meceda P, et al. Integrating routine hemoglobin A1c screening in blood donation: A strategy for early diabetes detection and donor health awareness. Transfusion. 2026;66(11):2262-2272. doi:10.1111/trf.70238
BibTeX
@article{Jamal2026,
author = {Jamal, Yaseen and Layon, Arlene and Michelin, Leonardo and Mateo, Desireny and Panesa, Deniece and Meceda, Pamela and Bevington, Scott and Hodghead, Kathryn and Bennett, Jenn and Powers, Lee and Pandey, Suchitra and Kieffer, Theodore and Pham, Tho},
title = {Integrating routine hemoglobin A1c screening in blood donation: A strategy for early diabetes detection and donor health awareness},
journal = {Transfusion},
year = {2026},
volume = {66},
number = {11},
pages = {2262--2272},
doi = {10.1111/trf.70238}
}
EUVIMED